Patients, charities and health officials have called for prescribers to stop issuing a diabetes drug for weight loss amid a national shortage for those most in need. Ozempic, which contains the active ingredient semaglutide, is licensed for managing blood sugar levels in people with type 2 diabetes. However it has quickly become famous as a… Continue reading Prescription of diabetes drug Ozempic for weight loss ‘contributing to UK shortage’ | Diabetes